Catalyst Wire Dossier Catalyst Wire Dossier

Elenestinib

elenestinib · Blueprint Medicines Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Elenestinib, covering 2025-04-10 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Elenestinib in Healthy Adult Female Participants [Phase 1]

See pricing